Securian Asset Management, Inc Abbott Laboratories Transaction History

Securian Asset Management, Inc

$3.39 Billion
Q4 2024

A detailed history of Securian Asset Management, Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Securian Asset Management, Inc holds 93,219 shares of ABT stock, worth $11.8 Million. This represents 0.31% of its overall portfolio holdings.

Number of Shares

93,219

Previous 96,230 3.13%

Holding current value

$11.8 Million

Previous $11 Million 3.89%

% of portfolio

0.31%

Previous 0.32%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 10, 2025	SELL	$111.93 - $119.39 $337,021 - $359,483	-3,011 Reduced 3.13%	93,219 $10.5 Million
Q3 2024 Nov 13, 2024	SELL	$100.07 - $118.13 $380,165 - $448,775	-3,799 Reduced 3.8%	96,230 $11 Million
Q2 2024 Jul 15, 2024	SELL	$100.73 - $112.44 $223,922 - $249,954	-2,223 Reduced 2.17%	100,029 $10.4 Million
Q1 2024 Apr 26, 2024	SELL	$109.52 - $120.96 $836,623 - $924,013	-7,639 Reduced 6.95%	102,252 $11.6 Million
Q4 2023 Feb 08, 2024	SELL	$90.19 - $110.4 $1.32 Million - $1.62 Million	-14,640 Reduced 11.76%	109,891 $12.1 Million
Q3 2023 Oct 30, 2023	SELL	$95.53 - $114.62 $1.86 Million - $2.23 Million	-19,441 Reduced 13.5%	124,531 $12.1 Million
Q2 2023 Aug 07, 2023	SELL	$100.78 - $112.29 $222,219 - $247,599	-2,205 Reduced 1.51%	143,972 $15.7 Million
Q1 2023 Apr 27, 2023	BUY	$96.86 - $114.01 $70,417 - $82,885	727 Added 0.5%	146,177 $14.8 Million
Q4 2022 Feb 02, 2023	SELL	$95.06 - $111.52 $42,016 - $49,291	-442 Reduced 0.3%	145,450 $16 Million
Q3 2022 Oct 28, 2022	BUY	$96.76 - $112.03 $62,990 - $72,931	651 Added 0.45%	145,892 $14.1 Million
Q2 2022 Aug 04, 2022	SELL	$102.07 - $123.37 $235,169 - $284,244	-2,304 Reduced 1.56%	145,241 $15.8 Million
Q1 2022 May 03, 2022	SELL	$114.02 - $139.04 $229,294 - $279,609	-2,011 Reduced 1.34%	147,545 $17.5 Million
Q4 2021 Feb 10, 2022	SELL	$115.53 - $141.46 $198,133 - $242,603	-1,715 Reduced 1.13%	149,556 $21 Million
Q3 2021 Nov 08, 2021	SELL	$116.66 - $129.06 $236,586 - $261,733	-2,028 Reduced 1.32%	151,271 $17.9 Million
Q2 2021 Aug 10, 2021	SELL	$105.79 - $124.53 $50,038 - $58,902	-473 Reduced 0.31%	153,299 $17.8 Million
Q1 2021 May 10, 2021	SELL	$108.84 - $128.23 $556,390 - $655,511	-5,112 Reduced 3.22%	153,772 $18.4 Million
Q4 2020 Feb 08, 2021	SELL	$105.0 - $114.42 $417,900 - $455,391	-3,980 Reduced 2.44%	158,884 $17.4 Million
Q3 2020 Nov 04, 2020	SELL	$91.64 - $111.29 $177,598 - $215,680	-1,938 Reduced 1.18%	162,864 $17.7 Million
Q2 2020 Aug 06, 2020	SELL	$76.57 - $98.0 $793,112 - $1.02 Million	-10,358 Reduced 5.91%	164,802 $15.1 Million
Q1 2020 May 07, 2020	SELL	$62.82 - $91.86 $188,083 - $275,028	-2,994 Reduced 1.68%	175,160 $13.8 Million
Q4 2019 Feb 04, 2020	SELL	$78.51 - $87.4 $516,674 - $575,179	-6,581 Reduced 3.56%	178,154 $15.5 Million
Q3 2019 Nov 12, 2019	SELL	$81.84 - $88.74 $86,586 - $93,886	-1,058 Reduced 0.57%	184,735 $15.5 Million
Q2 2019 Aug 05, 2019	BUY	$72.88 - $85.0 $160,700 - $187,425	2,205 Added 1.2%	185,793 $15.6 Million
Q1 2019 Apr 26, 2019	BUY	$66.22 - $80.06 $88,337 - $106,800	1,334 Added 0.73%	183,588 $14.7 Million
Q4 2018 Feb 04, 2019	BUY	$65.56 - $74.27 $104,568 - $118,460	1,595 Added 0.88%	182,254 $13.2 Million
Q3 2018 Oct 26, 2018	BUY	$60.81 - $73.36 $8,026 - $9,683	132 Added 0.07%	180,659 $13.3 Million
Q2 2018 Aug 09, 2018	BUY	$57.57 - $63.54 $111,570 - $123,140	1,938 Added 1.09%	180,527 $11 Million
Q1 2018 Apr 30, 2018	SELL	$56.27 - $63.62 $19,694 - $22,267	-350 Reduced 0.2%	178,589 $10.7 Million
Q4 2017 Feb 05, 2018	BUY	$53.68 - $57.47 $201,836 - $216,087	3,760 Added 2.15%	178,939 $10.2 Million
Q3 2017 Nov 03, 2017	BUY	$48.06 - $53.64 $5,911 - $6,597	123 Added 0.07%	175,179 $9.35 Million
Q2 2017 Aug 14, 2017	BUY	N/A	175,056	175,056 $8.51 Million

Others Institutions Holding ABT

# of Institutions

3,376

Shares Held

1.36B

Call Options Held

10.6M

Put Options Held

8.73M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $222B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Securian Asset Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Securian Asset Management, Inc with notifications on news.

Account

Securian Asset Management, Inc Abbott Laboratories Transaction History